ACT Genomics is a series b startup. 2 investors tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
ACT Genomics is a cancer solution provider. It offers a range of services including biomarker testing, drug development, and precision medicine.
Stage
series-b
Investors
2
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky